InstalabGLP-1 Safety & Monitoring Panel
Should you take a GLP-1 Safety & Monitoring Panel test?
This test is most useful if any of these apply to you.
51 biomarkers included
- Lipids5
- Total CholesterolSums all cholesterol in the blood, giving overall context to the more specific lipid markers.Why it mattersA downward trend supports broad lipid improvement, but the particle count tells the risk story more precisely.
- LDL CholesterolTracks the cholesterol most likely to build arterial plaque, modestly reduced by GLP-1 therapy.Why it mattersA persistently high LDL is a cue to consider adding cholesterol-lowering treatment.
- HDL CholesterolReflects the cholesterol your body clears from artery walls, adding balance to the lipid picture.Why it mattersLow HDL beside high triglycerides points to a metabolic pattern rather than a dietary one.
- VLDL CholesterolEstimates the liver's triglyceride-rich carrier particle (very low-density lipoprotein), tied to triglyceride metabolism.Why it mattersAn elevated value mirrors high triglycerides and flags residual fat-handling strain.
- TriglyceridesMeasures circulating blood fat that usually falls on these drugs and tracks closely with insulin resistance.Why it mattersA level that stays high suggests ongoing metabolic strain even as weight drops.
- Inflammation2
- hs-CRPA sensitive marker of low-grade inflammation (high-sensitivity C-reactive protein) that often falls with GLP-1 therapy.Why it mattersA drop signals cooling vascular inflammation; a stubborn level flags residual cardiovascular risk.
- Uric AcidA metabolic byproduct linked to gout and cardiometabolic strain, tracked as weight and diet shift.Why it mattersA high or rising level can flag gout risk worth managing alongside weight loss.
- Glucose Regulation4
- InsulinShows how hard your pancreas is working to hold blood sugar steady, a direct window into insulin resistance.Why it mattersA drop alongside stable glucose means your body now needs less insulin to do the same job.
- GlucoseA snapshot of blood sugar at the moment of the draw, useful for spotting lows when the drug is combined with other glucose-lowering medicines.Why it mattersAn unexpectedly low reading points to over-treatment when paired with insulin or a sulfonylurea.
- HbA1cReflects your average blood sugar over about three months, the main confirmation that the medication is controlling glucose.Why it mattersA falling number confirms the drug is working; a stalled number suggests the dose or overall plan needs revisiting.
- HOMA-IRA calculated insulin-resistance score built from fasting glucose and insulin together.Why it mattersA declining score signals improving insulin sensitivity, often before HbA1c fully reflects the change.
- Liver6
- AlbuminThe main blood protein, reflecting both nutrition and liver output as intake drops.Why it mattersA falling albumin can signal that undereating is starting to erode protein status.
- ALPAn enzyme from liver, bile ducts, and bone that helps flag bile-flow problems.Why it mattersAn elevation can signal gallbladder or bile-duct trouble, a risk these drugs raise independent of weight loss.
- ALTA liver enzyme that typically improves as fat leaves the liver on these drugs.Why it mattersA falling ALT reflects reduced liver fat; an unexplained climb prompts a closer hepatic look.
- ASTA liver and muscle enzyme that, with ALT, tracks liver health during weight loss.Why it mattersA rising AST out of step with ALT can point to muscle strain rather than liver stress.
- Total BilirubinA pigment cleared by the liver that rounds out the hepatic and bile-flow picture.Why it mattersA rise alongside high ALP raises concern for a bile-flow or gallbladder problem.
- Total GlobulinThe non-albumin protein fraction, tied to immune and inflammatory activity.Why it mattersAn unusual value shifts attention toward inflammation or immune causes rather than nutrition.
- Kidney3
- Total ProteinSums albumin and other proteins, adding context to nutritional and liver assessment.Why it mattersA decline with low albumin reinforces a picture of inadequate protein intake.
- BUNA kidney and hydration marker (blood urea nitrogen) that sharpens the dehydration picture.Why it mattersA high BUN relative to creatinine strongly suggests volume depletion from reduced intake.
- CreatinineThe core kidney-filtration marker, watched closely when nausea or vomiting risks dehydration.Why it mattersA climb during poor intake usually reflects dehydration rather than lasting kidney damage.
- Thyroid3
- TSHThe pituitary's thyroid signal (thyroid stimulating hormone), included as cautious surveillance during therapy.Why it mattersA modestly lower TSH may accompany weight loss and rarely reflects a direct drug effect.
- Free T4An active thyroid hormone that clarifies whether a shifted TSH reflects real thyroid change.Why it mattersA normal free T4 alongside a nudged TSH usually points away from true thyroid dysfunction.
- Free T3The most active thyroid hormone, completing the thyroid surveillance picture.Why it mattersStable free T3 with other normal thyroid values is reassuring against meaningful thyroid effect.
- Electrolytes5
- CalciumA mineral tied to bone and metabolism, tracked alongside vitamin D during weight loss.Why it mattersA low value with low vitamin D hints at a bone-nutrition shortfall worth correcting.
- ChlorideA salt that moves with sodium and helps map fluid and acid-base balance.Why it mattersShifts alongside bicarbonate help distinguish vomiting-related losses from other causes.
- SodiumThe main blood salt, sensitive to fluid losses from vomiting or diarrhea.Why it mattersA low sodium during GI upset points to dehydration and fluid imbalance.
- PotassiumAn electrolyte vital to heart rhythm that can shift with GI losses.Why it mattersAn abnormal level after persistent vomiting or diarrhea warrants prompt attention.
- BicarbonateReflects acid-base balance, which can drift with heavy vomiting or diarrhea.Why it mattersAn abnormal level signals the metabolic disturbance behind prolonged GI symptoms.
- Hormones1
- Total TestosteroneA hormone that usually rises as men shed excess weight, though a severe energy deficit during rapid loss can lower it.Why it mattersA low level during very rapid weight loss may reflect low energy availability rather than a primary hormonal problem.
- Vitamins3
- Vitamin D (25-hydroxy)The best-supported deficiency signal on these drugs, and often low before treatment even starts.Why it mattersA falling level is the most common nutrient shortfall seen after starting GLP-1 therapy.
- Vitamin B12A nutrient for nerves and red blood cells that can slip when appetite and intake fall.Why it mattersA low level can drive fatigue and, over time, anemia or nerve symptoms.
- Vitamin B9 (Folate)Folate, needed for red blood cell production and cell repair as food intake drops.Why it mattersA shortfall can enlarge red blood cells and contribute to anemia.
- Red Blood Cells8
- RBC CountThe number of red blood cells, anchoring the anemia assessment.Why it mattersA low count supports an anemia picture when hemoglobin is also falling.
- HemoglobinThe oxygen-carrying protein in red blood cells, central to detecting anemia from undereating.Why it mattersA drop suggests anemia developing from reduced iron, B12, or folate intake.
- HematocritThe share of blood made up of red cells, sensitive to both anemia and dehydration.Why it mattersA rise can flag dehydration from vomiting; a fall points to developing anemia.
- MCVThe average red blood cell size, a useful nutrient clue.Why it mattersEnlarged cells hint at B12 or folate shortfall; small cells point toward iron deficiency.
- MCHThe average amount of hemoglobin per red cell, refining the anemia type.Why it mattersA low value reinforces an iron-deficiency pattern seen with small red cells.
- MCHCThe hemoglobin concentration inside red cells, adding detail to anemia typing.Why it mattersA low value adds weight to an iron-related anemia interpretation.
- RDWThe variation in red cell size, often the earliest quantitative nutrient clue.Why it mattersA rising spread can be the first hint of a developing nutrient deficiency.
- MPVThe average platelet size, reflecting how actively your marrow replaces platelets.Why it mattersA larger average size shows the marrow is turning over platelets quickly.
- Lipoproteins1
- ApoBCounts the atherogenic particles (apolipoprotein B) that carry cholesterol into artery walls, a sharper heart-risk read than cholesterol alone.Why it mattersIf ApoB stays high while sugar improves, arterial risk persists despite good glucose numbers.
- Immune Function6
- WBC CountThe total white blood cell tally, a general marker of infection or inflammation.Why it mattersAn unexplained rise can flag infection unrelated to the medication.
- Neutrophil CountThe white cells that fight bacteria, the workhorse of the immune tally.Why it mattersAn elevated count typically points to a bacterial infection or acute stress.
- Monocyte CountImmune cells involved in cleanup and chronic inflammation.Why it mattersA rise can accompany chronic inflammation worth investigating.
- Lymphocyte CountImmune cells that respond to viruses and coordinate longer-term defense.Why it mattersShifts can reflect viral illness or, with other counts, broader immune change.
- Eosinophil CountWhite cells linked to allergy and reactions rather than metabolism.Why it mattersAn elevation may flag an allergy or drug reaction, not a metabolic problem.
- Basophil CountThe rarest white cells, occasionally raised in allergic or marrow conditions.Why it mattersA rise is uncommon and prompts a look for allergic or marrow-related causes.
- Blood Clotting1
- Platelet CountClotting cells that also feed liver-fibrosis scoring alongside the enzymes.Why it mattersFalling platelets combined with liver enzymes can flag emerging liver scarring.
- Gastrointestinal2
- AmylaseA second pancreatic enzyme that corroborates lipase when pancreatic irritation is suspected.Why it mattersAn isolated rise without symptoms usually reflects a drug effect, not true pancreatic injury.
- LipaseThe preferred pancreatic enzyme for detecting irritation of the pancreas, checked when abdominal symptoms appear.Why it mattersA rise paired with abdominal pain or vomiting warrants prompt clinical evaluation for pancreatitis.
- Iron Studies1
- FerritinThe body's iron-storage marker, a sensitive early sign of falling iron intake.Why it mattersA declining ferritin is often the first hint of iron depletion from reduced eating.
About GLP-1 Safety & Monitoring Panel
Drugs like semaglutide and tirzepatide act on gut-hormone pathways: semaglutide imitates a hormone called GLP-1, while tirzepatide is a dual agonist that acts on both GLP-1 and a related receptor called GIP. Either way, they change several systems at once. They lower blood sugar, shift your cholesterol, shrink fat stores, and quietly cut how much you eat.
That broad reach is exactly why a single before-and-after sugar or cholesterol check misses most of the story. This panel reads the whole response in one blood draw: the improvements you want to confirm, and the short list of side effects worth keeping an eye on.
What This Panel Reveals
The core question is whether the drug is remodeling your metabolism, not just nudging one number. The sugar markers answer that from different angles: glucose is a snapshot at the moment of the draw, HbA1c (a roughly three-month blood sugar average) captures the trend, and fasting insulin with HOMA-IR (a calculated insulin-resistance score) show whether your body needs less insulin to hold steady. In trials, tirzepatide at its 15 mg dose produced the largest average drop in HbA1c, roughly 2 percentage points versus placebo, with the exact figure varying by dose, and fasting glucose fell alongside it.
The heart-risk markers show whether better sugar is translating into a safer set of arteries. ApoB (apolipoprotein B, a count of the particles that drive cholesterol into artery walls), triglycerides, LDL, and hs-CRP (high-sensitivity C-reactive protein, a marker of low-grade inflammation) tend to improve together on these drugs. In one analysis semaglutide lowered LDL cholesterol by about 0.16 mmol/L and total cholesterol by roughly 0.17 mmol/L, a modest shift, while newer GLP-1 studies show ApoB and hs-CRP falling alongside triglycerides. Uric acid rounds out the metabolic-strain picture.
The safety side watches the organs most exposed to the drug's effects. Lipase and amylase screen for pancreatic irritation, the liver enzymes (ALT, AST, ALP) and bilirubin track a liver that usually improves as fat leaves it while also flagging gallbladder and bile-duct trouble, which these drugs make more likely independent of weight loss. The kidney and electrolyte markers (creatinine, BUN, sodium, potassium, chloride, bicarbonate, calcium) separate dehydration from the mostly kidney-protective pattern these drugs show. In pooled trial data, semaglutide and liraglutide reduced protein leaking into the urine by 24 percent over two years.
The last group covers what happens when you eat far less. The micronutrient and protein markers (vitamin D, vitamin B12, vitamin B9, ferritin, albumin, total protein) flag emerging shortfalls, and the complete blood count (CBC, a full tally of red cells, white cells, and platelets) catches anemia from undereating. Testosterone usually rises as men shed excess weight, but a severe energy deficit during very rapid loss can push it down, so it is tracked as context. Thyroid tests (TSH, free T4, free T3) sit here as cautious surveillance rather than a proven drug effect, because the human thyroid link remains unsettled.
How to Read Your Results Together
The value of the panel is in the combinations, not any one line. A few patterns come up often enough to be worth recognizing in your own results.
| Pattern | What It Suggests |
|---|---|
| HbA1c and glucose falling, but ApoB and hs-CRP unchanged | Sugar is improving while arterial risk persists. Adding lipid-lowering therapy may matter more than sugar control alone. |
| Creatinine and BUN rising with low sodium during heavy nausea or vomiting | Dehydration from reduced intake, not primary kidney disease. Rehydration and a symptom check usually come first. |
| Isolated lipase or amylase rise with no abdominal pain | Most often a drug effect rather than pancreatitis. These enzymes predict actual pancreatitis poorly on their own. |
| Ferritin, B12, or vitamin D dropping with low albumin and falling hemoglobin | Undereating is outpacing nutrition. Protein and micronutrient support, not stopping the drug, is the usual next step. |
What to Do with Your Results
Most improvements need no action beyond confirming the direction and continuing. The results that warrant follow-up are a lipase or amylase rise paired with real abdominal pain or vomiting, a meaningful climb in creatinine during a stretch of poor intake, and micronutrient or protein markers sliding as weight falls fast. Pancreatic enzymes with symptoms point toward a clinician visit; a rising creatinine points toward hydration and a medication review; falling nutrition markers point toward more protein, resistance training to protect muscle, and targeted supplementation.
Serial tracking is where this panel earns its place. A sensible rhythm is a baseline before or near starting, a recheck after you reach your maintenance dose, and every three to six months while weight is actively changing. What matters between draws is the trajectory: sugar and lipid markers should be trending down, kidney and liver markers should hold steady, and nutrition markers should not be quietly eroding. If you want a sharper heart-risk read, an Lp(a) test adds a genetic layer; if muscle loss is a concern, body-composition scanning complements the blood work.
When Results Can Be Misleading
Several confounders hit multiple tests at once. Fasting status swings glucose, insulin, and triglycerides together, so a non-fasting draw can look worse than your true baseline. A recent bout of vomiting or diarrhea can shift electrolytes, push up kidney markers, and concentrate the blood count all at the same time, mimicking disease that is really just dehydration. And a draw taken right after a dose increase, when nausea peaks, tends to show the panel at its most stressed rather than at its steady state.